Hui-Ying Huang Selected Research

danthron

8/2012	Danthron triggers ROS and mitochondria-mediated apoptotic death in C6 rat glioma cells through caspase cascades, apoptosis-inducing factor and endonuclease G multiple signaling.
1/2011	Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Ying Huang Research Topics

Disease

6	Neoplasms (Cancer) 05/2014 - 10/2010
3	Malaria 03/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 11/2022 - 11/2021
2	Squamous Cell Carcinoma of Head and Neck 05/2022 - 11/2021
2	Atrophic Gastritis 02/2022 - 10/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2014 - 01/2012
2	Colonic Neoplasms (Colon Cancer) 05/2012 - 10/2010
1	Restless Legs Syndrome (Restless Legs) 03/2022
1	Hyperkinesis 03/2022
1	Insulin Resistance 01/2021
1	Infections 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2018
1	Necrosis 05/2014
1	Lung Neoplasms (Lung Cancer) 05/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2013
1	Iron Deficiencies 05/2013
1	Glioma (Gliomas) 08/2012
1	Anemia 07/2012
1	Hyponatremia 07/2012
1	Liver Neoplasms (Liver Cancer) 05/2012
1	Tongue Neoplasms (Tongue Neoplasm) 05/2012
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2012
1	Skin Neoplasms (Skin Cancer) 01/2012
1	Melanoma (Melanoma, Malignant) 01/2012
1	Stomach Neoplasms (Stomach Cancer) 01/2011
1	AIDS-Related Complex (ARC) 11/2010
1	Hypertension (High Blood Pressure) 11/2010
1	Diabetes Mellitus 11/2010
1	Hypoalbuminemia 02/2010
1	Body Weight (Weight, Body) 02/2010
1	Postmenopausal Osteoporosis 08/2006

Drug/Important Bio-Agent (IBA)

4	AnthraquinonesIBA 05/2014 - 01/2011
3	CaspasesIBA 08/2012 - 01/2011
2	chrysophanic acidIBA 05/2014 - 05/2012
2	IronIBA 05/2013 - 01/2012
2	endonuclease GIBA 08/2012 - 01/2011
2	danthronIBA 08/2012 - 01/2011
2	Apoptosis Inducing FactorIBA 08/2012 - 01/2011
2	Cytochromes c (Cytochrome c)IBA 01/2012 - 01/2011
2	Caspase 9IBA 01/2012 - 01/2011
2	AlbuminsIBA 11/2010 - 02/2010
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 11/2022
1	MorpholinosIBA 03/2022
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 03/2021
1	VaccinesIBA 03/2021
1	AdiponectinIBA 01/2021
1	LeptinIBA 01/2021
1	glucose-6-phosphate dehydrogenase A-IBA 01/2020
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2020
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	proanthocyanidinIBA 07/2018
1	AntioxidantsIBA 07/2018
1	LipidsIBA 07/2018
1	Ellagic AcidIBA 11/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2014
1	ElectrolytesIBA 07/2012
1	allyl sulfideIBA 05/2012
1	Pharmaceutical PreparationsIBA 05/2012
1	amsonic acid (DAS)IBA 05/2012
1	diallyl disulfide (diallyl disulphide)IBA 05/2012
1	diallyl trisulfideIBA 05/2012
1	Capsaicin (Zostrix)FDA Link 05/2012
1	DAPIIBA 05/2012
1	Adenosine Triphosphate (ATP)IBA 05/2012
1	naringeninIBA 01/2012
1	CalciumIBA 01/2012
1	Caspase 8 (Caspase-8)IBA 01/2012
1	Bee Venoms (Bee Venom)IBA 01/2012
1	VenomsIBA 01/2012
1	Caspase 3 (Caspase-3)IBA 01/2012
1	bufalinIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	FullerenesIBA 11/2010
1	HydrogenIBA 11/2010
1	ChlorineIBA 11/2010
1	phenethyl isothiocyanate (PEITC)IBA 10/2010
1	Hemoglobins (Hemoglobin)IBA 02/2010
1	IsoflavonesIBA 08/2006

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 05/2022 - 05/2012
2	Moxibustion 02/2022 - 10/2017
2	Long-Term Care 05/2013 - 07/2012
1	Therapeutics 05/2022
1	Catheters 07/2012
1	Tracheostomy 07/2012
1	Radiotherapy 05/2012